Jove
Visualize
お問い合わせ

関連する概念動画

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

72
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
72
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

196
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
196
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

75
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. 胃がん手術後の急性腎臓損傷に対するセボフルラン基またはプロポフール基麻酔の効果: 後向きの傾向スコアマッチ分析
  1. ホーム
  2. 胃がん手術後の急性腎臓損傷に対するセボフルラン基またはプロポフール基麻酔の効果: 後向きの傾向スコアマッチ分析

関連する実験動画

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K

胃がん手術後の急性腎臓損傷に対するセボフルラン基またはプロポフール基麻酔の効果: 後向きの傾向スコアマッチ分析

Yang Song1, Si Liang2,3, Ming Wei1

  • 1Department of Anesthesiology, Harbin Medical University Cancer Hospital, No. 150 Haping Rd., Nangang District, Harbin, 150081, China.

BMC anesthesiology
|August 27, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

この研究では,プロポフォールベースの全静脈麻酔 (TIVA) とセボフルランベースの吸入麻酔 (INHA) を比較したところ,胃がん手術後の急性腎臓損傷 (AKI) 率に有意な差は認められなかった. 両方の麻酔方法は,手術後の腎臓機能に関する同様の安全性プロファイルを示した.

キーワード:
急性腎臓損傷胃がん吸入麻酔リオペラティブの推定グルメルフィルタレーション率静脈内麻酔

さらに関連する動画

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.4K
In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

6.7K

関連する実験動画

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.4K
In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

6.7K

科学分野:

  • 麻酔科
  • 腎臓科
  • 手術腫瘍学

背景:

  • 急性腎損傷 (AKI) は,大きな腹部手術,特に胃がん手術後の重大な合併症です.
  • AKIは患者の死亡率と有害な結果の増加と関連しています.
  • AKIのリスクを軽減する麻酔の戦略を特定することは,手術結果を改善するために極めて重要です.

研究 の 目的:

  • 胃がん手術を受けた患者の術後のAKIの発生率を比較する.
  • AKIに関するセボフルーランベースの吸入麻酔 (INHA) と対比してプロポフォールベースの全麻酔 (TIVA) の安全性を評価する.
  • この患者集団における麻酔薬の選択が AKI 率に影響するかどうかを判断する.

主な方法:

  • ハルビン医科大学がん病院 (2010年−2018年) の胃がん手術患者の医療記録の遡及分析.
  • 比較可能なグループを作成するために,傾向スコアのマッチングが採用されました.
  • プロポフォールTIVAとセボフルランINHA群の間で,最初の3日間のAKIの発生率を比較した.

主要な成果:

  • 最初,合計3533人の患者が対象となり,1206人が麻酔用グループにマッチングされた.
  • ロジスティック回帰では,プロポフロールとセボフルーランのグループ間のAKI発生率において,マッチング前 (OR1. 05) とマッチング後 (OR1. 02) の両方で有意な差異は見られなかった.
  • 比較後のAKIの発生率はセボフルランの5. 0%,プロポフールの5. 1%で,比較可能な割合を示しています.
  • 結論:

    • 胃切除術後のAKIの統計的に有意な差は示されていない.
    • プロポフォール基のTIVAとセボフルラン基のINHAは,胃がん手術の患者におけるAKIリスクに関して,類似した安全性プロファイルを持っているようです.
    • プロポフォールとセボフルーランの間の麻酔の選択は,胃切除術後のAKIの発症の可能性に有意な影響を与えない.